NASDAQ:RNA - Nasdaq - US05370A1088 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 10.12M | 9.56M | 9.22M | 9.33M | 6.79M | |||
Operating Expenses | 334.81M | 245.16M | 188.14M | 127.38M | 51.06M | |||
Research and Development | 260.79M | 190.97M | 150.40M | 101.18M | 37.60M | |||
Selling, General, and Administrative Expenses | 74.02M | 54.19M | 37.73M | 26.20M | 13.46M | |||
Operating Income | -324.69M | -235.60M | -178.91M | -118.05M | -44.28M | |||
Interest Income/Expense | 44.76M | 23.97M | 4.98M | 100.00K | 0.00 | |||
Other Income/Expense | -554.00K | -594.00K | -60.00K | -60.00K | -80.00K | |||
Income Before Taxes | -280.49M | -212.22M | -174.00M | -118.01M | -44.36M | |||
Net Income | -280.49M | -212.22M | -174.00M | -118.01M | -44.36M | |||
EBITDA | -322.04M | -233.50M | -177.52M | -117.41M | -43.91M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -2.90 | -2.91 | -3.34 | -2.85 | -1.18 | |||
Non GAAP EPS | -2.88 | -2.90 | -3.33 | -2.84 | N/A | |||
Statistics | ||||||||
Profit Margin | -2772.45% | -2219.87% | -1887.20% | -1264.84% | -653.31% | |||
Operating Profit Margin | -3209.35% | -2464.41% | -1940.46% | -1265.27% | -652.14% |
All data in USD